127 related articles for article (PubMed ID: 27604259)
21. Expression of prothrombin, thrombin and its receptors in human scars.
Artuc M; Hermes B; Algermissen B; Henz BM
Exp Dermatol; 2006 Jul; 15(7):523-9. PubMed ID: 16761961
[TBL] [Abstract][Full Text] [Related]
22. Glycosaminoglycan contributions to both protein C activation and thrombin inhibition involve a common arginine-rich site in thrombin that includes residues arginine 93, 97, and 101.
Ye J; Rezaie AR; Esmon CT
J Biol Chem; 1994 Jul; 269(27):17965-70. PubMed ID: 8027055
[TBL] [Abstract][Full Text] [Related]
23. [Discovery and prospects of a novel thrombophilia: antithrombin resistance].
Takagi Y; Kojima T
Nihon Rinsho; 2014 Jul; 72(7):1320-4. PubMed ID: 25163329
[TBL] [Abstract][Full Text] [Related]
24. Naturally occurring mutations in the thrombomodulin gene leading to impaired expression and function.
Kunz G; Ohlin AK; Adami A; Zöller B; Svensson P; Lane DA
Blood; 2002 May; 99(10):3646-53. PubMed ID: 11986219
[TBL] [Abstract][Full Text] [Related]
25. Thrombomodulin improved liver injury, coagulopathy, and mortality in an experimental heatstroke model in mice.
Kawasaki T; Okamoto K; Kawasaki C; Sata T
Anesth Analg; 2014 May; 118(5):956-63. PubMed ID: 24781566
[TBL] [Abstract][Full Text] [Related]
26. Gly74Ser mutation in protein C causes thrombosis due to a defect in protein S-dependent anticoagulant function.
Chen C; Yang L; Villoutreix BO; Wang X; Ding Q; Rezaie AR
Thromb Haemost; 2017 Jun; 117(7):1358-1369. PubMed ID: 28405673
[TBL] [Abstract][Full Text] [Related]
27. Thrombomodulin enhances the invasive activity of mouse mammary tumor cells.
Niimi S; Harashima M; Takayama K; Hara M; Hyuga M; Seki T; Ariga T; Kawanishi T; Hayakawa T
J Biochem; 2005 May; 137(5):579-86. PubMed ID: 15944410
[TBL] [Abstract][Full Text] [Related]
28. The technique of measuring thrombin generation with fluorogenic substrates: 3. The effects of sample dilution.
De Smedt E; Wagenvoord R; Coen Hemker H
Thromb Haemost; 2009 Jan; 101(1):165-70. PubMed ID: 19132204
[TBL] [Abstract][Full Text] [Related]
29. Lys 42/43/44 and Arg 12 of thrombin-activable fibrinolysis inhibitor comprise a thrombomodulin exosite essential for its antifibrinolytic potential.
Wu C; Stafford AR; Fredenburgh JC; Weitz JI; Gils A; Declerck PJ; Kim PY
Thromb Haemost; 2017 Jul; 117(8):1509-1517. PubMed ID: 28640323
[TBL] [Abstract][Full Text] [Related]
30. Activation of protein C by the thrombin-thrombomodulin complex: cooperative roles of Arg-35 of thrombin and Arg-67 of protein C.
Yang L; Manithody C; Rezaie AR
Proc Natl Acad Sci U S A; 2006 Jan; 103(4):879-84. PubMed ID: 16418283
[TBL] [Abstract][Full Text] [Related]
31. The development of inflammatory joint disease is attenuated in mice expressing the anticoagulant prothrombin mutant W215A/E217A.
Flick MJ; Chauhan AK; Frederick M; Talmage KE; Kombrinck KW; Miller W; Mullins ES; Palumbo JS; Zheng X; Esmon NL; Esmon CT; Thornton S; Becker A; Pelc LA; Di Cera E; Wagner DD; Degen JL
Blood; 2011 Jun; 117(23):6326-37. PubMed ID: 21436072
[TBL] [Abstract][Full Text] [Related]
32. Study on complex formation between recombinant human thrombomodulin fragment and thrombin using surface plasmon resonance.
Kishida A; Nakashima M; Sakamoto N; Serizawa T; Maruyama I; Akashi M
Am J Hematol; 2000 Mar; 63(3):136-40. PubMed ID: 10679803
[TBL] [Abstract][Full Text] [Related]
33. Effects of recombinant human soluble thrombomodulin (rhs-TM) on clot-induced coagulation in human plasma.
Mohri M; Suzuki M; Sugimoto E; Sata M; Yamamoto S; Maruyama I
Thromb Haemost; 1998 Dec; 80(6):925-9. PubMed ID: 9869162
[TBL] [Abstract][Full Text] [Related]
34. A missense mutation in lectin domain of thrombomodulin causing functional deficiency.
Jiewen M; Yanyi T; Yuanzheng F; Zhipeng C; Wenyi L; Bei H; Yu H; Tang LV
Transl Res; 2023 Jan; 251():74-83. PubMed ID: 35921923
[TBL] [Abstract][Full Text] [Related]
35. A recombinant murine meizothrombin precursor, prothrombin R157A/R268A, inhibits thrombosis in a model of acute carotid artery injury.
Shim K; Zhu H; Westfield LA; Sadler JE
Blood; 2004 Jul; 104(2):415-9. PubMed ID: 15039280
[TBL] [Abstract][Full Text] [Related]
36. Functional characterization of thrombin Salakta: an abnormal thrombin derived from a human prothrombin variant.
Bezeaud A; Elion J; Guillin MC
Blood; 1988 Mar; 71(3):556-61. PubMed ID: 2830924
[TBL] [Abstract][Full Text] [Related]
37. [Effect of rabbit thrombomodulin on the inhibition of thrombin by the antithrombin-heparin complex: role of the acid domain of thrombomodulin].
Bourin MC
C R Acad Sci III; 1987; 304(8):173-6. PubMed ID: 3028582
[TBL] [Abstract][Full Text] [Related]
38. Role of Leu99 of thrombin in determining the P2 specificity of serpins.
Rezaie AR
Biochemistry; 1997 Jun; 36(24):7437-46. PubMed ID: 9200692
[TBL] [Abstract][Full Text] [Related]
39. Heparin, coumarin, protein C, antithrombin, fibrinolysis and other clotting related resistances: old and new concepts in blood coagulation.
Girolami A; Cosi E; Ferrari S; Girolami B
J Thromb Thrombolysis; 2018 Jan; 45(1):135-141. PubMed ID: 29063359
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of invasion and experimental metastasis of murine melanoma cells by human soluble thrombomodulin.
Hosaka Y; Higuchi T; Tsumagari M; Ishii H
Cancer Lett; 2000 Dec; 161(2):231-40. PubMed ID: 11090974
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
